NO911723L - Pyrido(2,3-f)(1,4)tiazepiner og pyrido(3,2-b)(1,5)benzotiazepiner. - Google Patents

Pyrido(2,3-f)(1,4)tiazepiner og pyrido(3,2-b)(1,5)benzotiazepiner.

Info

Publication number
NO911723L
NO911723L NO91911723A NO911723A NO911723L NO 911723 L NO911723 L NO 911723L NO 91911723 A NO91911723 A NO 91911723A NO 911723 A NO911723 A NO 911723A NO 911723 L NO911723 L NO 911723L
Authority
NO
Norway
Prior art keywords
pyrido
tiazepines
benzotiazepines
novel
compounds
Prior art date
Application number
NO91911723A
Other languages
English (en)
Other versions
NO179411B (no
NO911723D0 (no
NO179411C (no
Inventor
David J Wustrow
John H Dodd
Charles F Schwender
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO911723D0 publication Critical patent/NO911723D0/no
Publication of NO911723L publication Critical patent/NO911723L/no
Publication of NO179411B publication Critical patent/NO179411B/no
Publication of NO179411C publication Critical patent/NO179411C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
NO911723A 1990-05-03 1991-05-02 Fremgangsmåte for fremstilling av pyrido[2,3-fÅ[1,4Åtiazepiner og pyrido[3,2-bÅ[1,5Åbenzotiazepiner NO179411C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/518,351 US5075440A (en) 1990-05-03 1990-05-03 Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines

Publications (4)

Publication Number Publication Date
NO911723D0 NO911723D0 (no) 1991-05-02
NO911723L true NO911723L (no) 1991-11-04
NO179411B NO179411B (no) 1996-06-24
NO179411C NO179411C (no) 1996-10-02

Family

ID=24063558

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911723A NO179411C (no) 1990-05-03 1991-05-02 Fremgangsmåte for fremstilling av pyrido[2,3-fÅ[1,4Åtiazepiner og pyrido[3,2-bÅ[1,5Åbenzotiazepiner

Country Status (25)

Country Link
US (1) US5075440A (no)
EP (1) EP0462696B1 (no)
JP (1) JP3296499B2 (no)
KR (1) KR100195345B1 (no)
CN (2) CN1034077C (no)
AT (1) ATE126231T1 (no)
AU (1) AU651580B2 (no)
CA (1) CA2041594C (no)
DE (1) DE69111915T2 (no)
DK (1) DK0462696T3 (no)
ES (1) ES2079570T3 (no)
FI (1) FI95912C (no)
GR (1) GR3017305T3 (no)
HK (1) HK51496A (no)
HU (1) HU218909B (no)
IE (1) IE68524B1 (no)
IL (6) IL120446A0 (no)
MY (1) MY106552A (no)
NO (1) NO179411C (no)
NZ (1) NZ237988A (no)
PT (1) PT97547B (no)
TN (1) TNSN91030A1 (no)
TW (1) TW218878B (no)
ZA (1) ZA913319B (no)
ZW (1) ZW5291A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031059A1 (en) * 1997-12-18 1999-06-24 Abbott Laboratories Potassium channel openers
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
US6593335B1 (en) 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
JPH11193289A (ja) * 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド誘導体
US6482854B1 (en) * 1999-03-25 2002-11-19 Massachusetts Eye And Ear Infirmary Glaucoma treatment
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
DE60005349T2 (de) * 1999-06-14 2004-12-30 Ortho-Mcneil Pharmaceutical, Inc. Dithiepino[6,5-b]pyridine und diese verwendete zusamensetzungen und methode
CZ2002126A3 (cs) * 1999-07-12 2003-04-16 Ortho-Mcneil Pharmaceutical, Inc. Oxathiepino [6,5-b] dihydropyridiny
AU7102700A (en) * 1999-09-22 2001-04-24 Ortho-Mcneil Pharmaceutical, Inc. Benzo-fused dithiepino[6,5-b]pyridines, and related compositions and methods
DK1246828T3 (da) 2000-01-12 2006-04-03 Ortho Mcneil Pharm Inc Benzosulfoner med calciummantagonist-aktivitet
AU783503B2 (en) * 2000-01-27 2005-11-03 Ortho-Mcneil Pharmaceutical, Inc. Benzoxathiepino(3,4-b)pyridine derivatives, process for their preparation and their use as medicaments
US6420383B1 (en) 2000-03-23 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Thiepino[3,2-b]dihydropyridines and related compositions and methods
WO2001092267A2 (en) 2000-05-30 2001-12-06 Ortho-Mcneil Pharmaceutical, Inc. Dihydropyridine compounds for the inhibition of calcium-influx
KR101233139B1 (ko) 2011-04-21 2013-02-21 주식회사 한서켐 라세믹 1,4-티아제핀 화합물의 분할 방법
KR20170102504A (ko) * 2014-12-30 2017-09-11 마이오데릭스, 인코포레이티드 신규한 칼슘 조절제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1587128A (en) * 1977-04-07 1981-04-01 Hexachimie Benzothiazepine derivatives
US4285955A (en) * 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
FR2511683A1 (fr) * 1981-08-20 1983-02-25 Hexachimie Nouveaux derives de la pyrido (2,3-b) benzothiazepine(1,5) substituee en 5 par une carboxypiperazine, leur procede de preparation, leur application en therapeutique
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
CN1118783A (zh) 1996-03-20
IL120447A0 (en) 1997-07-13
IL120446A0 (en) 1997-07-13
FI912124A0 (fi) 1991-05-02
HUT60745A (en) 1992-10-28
IL97999A0 (en) 1992-06-21
NO179411B (no) 1996-06-24
ES2079570T3 (es) 1996-01-16
CA2041594C (en) 2002-07-23
TNSN91030A1 (fr) 1992-10-25
DK0462696T3 (da) 1995-09-18
ATE126231T1 (de) 1995-08-15
CN1034077C (zh) 1997-02-19
CN1056880A (zh) 1991-12-11
JP3296499B2 (ja) 2002-07-02
JPH04225986A (ja) 1992-08-14
IL127047A (en) 2000-10-31
NZ237988A (en) 1992-09-25
EP0462696A1 (en) 1991-12-27
PT97547A (pt) 1992-01-31
GR3017305T3 (en) 1995-12-31
ZW5291A1 (en) 1993-01-06
US5075440A (en) 1991-12-24
AU651580B2 (en) 1994-07-28
HK51496A (en) 1996-03-29
CN1039416C (zh) 1998-08-05
DE69111915D1 (de) 1995-09-14
DE69111915T2 (de) 1996-01-04
IL120447A (en) 1999-12-22
IL97999A (en) 1997-06-10
FI95912C (fi) 1996-04-10
MY106552A (en) 1995-06-30
ZA913319B (en) 1993-01-27
NO911723D0 (no) 1991-05-02
IE911488A1 (en) 1991-11-06
TW218878B (no) 1994-01-11
IL127047A0 (en) 1999-09-22
KR910020019A (ko) 1991-12-19
IL120446A (en) 2000-08-31
FI912124A (fi) 1991-11-04
IE68524B1 (en) 1996-06-26
NO179411C (no) 1996-10-02
PT97547B (pt) 1998-08-31
HU911476D0 (en) 1991-11-28
EP0462696B1 (en) 1995-08-09
CA2041594A1 (en) 1991-11-04
FI95912B (fi) 1995-12-29
KR100195345B1 (ko) 1999-06-15
HU218909B (hu) 2000-12-28
AU7635491A (en) 1991-11-07

Similar Documents

Publication Publication Date Title
NO911723L (no) Pyrido(2,3-f)(1,4)tiazepiner og pyrido(3,2-b)(1,5)benzotiazepiner.
ES2056381T3 (es) Preparacion de intermedios diazabiciclos.
IE870913L (en) THIACYCLOALKANO (3,2-b) PYRIDINES
ES2053474T3 (es) 1,2,3-tiadazol-4-tiolatos substituidos.